| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 0.0 | 0.0 | −14.2% |
| EBITDA | −0.0 | −0.0 | — |
| EBITDA margin | −109.8% | −167.8% | +58.0 pts |
| Profit before tax | −0.0 | −0.0 | — |
| Net profit | −0.0 | −0.0 | — |
| EPS | −₹0.08 | −₹0.14 | — |
| Tap a line for its trend | Q1 FY27Jun 2026 | Q4 FY26Mar 2026 | Q3 FY26Dec 2025 | Q2 FY26Sep 2025 | Q1 FY26Jun 2025 | Q4 FY25Mar 2025 | Q3 FY25Dec 2024 | Q2 FY25Sep 2024 | Q1 FY25Jun 2024 | Q4 FY24Mar 2024 | Q3 FY24Dec 2023 | Q2 FY24Sep 2023 | Earlier quartersAlpha Plus |
|---|
| 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | −0.0 | 0.0 | 0.3 | 0.0 | 0.2 | 0.5 | 0.0 | Earlier quartersEvery year the company has filed comes with Alpha Plus. | |
| 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | −0.0 | 0.0 | 0.3 | 0.0 | 0.2 | 0.5 | 0.0 | ||
Expenses | |||||||||||||
| 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | −0.0 | 0.0 | 0.3 | 0.0 | 0.4 | 0.2 | 0.0 | ||
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| 0.0 | 0.1 | 0.1 | 0.0 | 0.1 | −0.0 | 0.0 | 0.3 | 0.1 | 0.4 | 0.2 | 0.0 | ||
| −0.0 | −0.0 | 0.1 | −0.0 | −0.0 | 0.0 | 0.0 | 0.0 | −0.0 | −0.3 | 0.3 | 0.0 | ||
| −0.0 | −0.0 | 0.1 | −0.0 | −0.0 | 0.0 | 0.0 | 0.0 | −0.0 | −0.3 | 0.3 | 0.0 | ||
Profit | |||||||||||||
| −0.0 | 0.1 | 0.1 | −0.0 | −0.0 | 0.0 | 0.0 | 0.0 | −0.0 | −0.3 | 0.3 | −0.0 | ||
| −0.0 | 0.1 | 0.1 | −0.0 | −0.0 | 0.0 | 0.0 | 0.0 | −0.0 | −0.3 | 0.3 | −0.0 | ||
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −0.1 | 0.1 | −0.0 | ||
| 0.0 | 0.0 | −0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −0.1 | 0.1 | −0.0 | ||
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| −0.0 | 0.1 | 0.1 | −0.0 | −0.0 | 0.0 | 0.0 | 0.0 | −0.0 | −0.2 | 0.2 | 0.0 | ||
| −0.0 | 0.1 | 0.1 | −0.0 | −0.0 | 0.0 | 0.0 | 0.0 | −0.0 | −0.2 | 0.2 | 0.0 | ||
| 17.3 | −61.1 | 31.6 | −10.6 | 2.9 | −68.4 | −19.2 | 10.2 | 20.9 | 28.2 | −3.2 | 3.6 | ||
| 17.3 | −61.0 | 31.7 | −10.6 | 2.8 | −68.4 | −19.1 | 10.2 | 20.9 | 28.0 | −2.9 | 3.6 | ||
Per share | |||||||||||||
| −₹0.08 | ₹0.18 | ₹0.17 | −₹0.02 | −₹0.14 | ₹0.04 | ₹0.04 | ₹0.10 | −₹0.04 | −₹0.64 | ₹0.77 | ₹0.00 | ||
| −₹0.08 | ₹0.18 | ₹0.17 | −₹0.02 | −₹0.14 | ₹0.04 | ₹0.04 | ₹0.10 | −₹0.04 | −₹0.64 | ₹0.77 | ₹0.00 | ||
Other comprehensive income — detail | |||||||||||||
| 17.3 | −61.1 | 31.6 | −10.6 | 2.9 | −68.4 | — | — | — | — | — | — | ||
| 17.3 | −61.1 | 31.6 | −10.6 | 2.9 | −68.4 | −19.2 | 10.2 | 20.9 | 28.2 | −3.2 | 3.6 | ||
Per share — as-filed variants | |||||||||||||
| −₹0.08 | ₹0.18 | ₹0.17 | −₹0.02 | −₹0.14 | ₹0.02 | ₹0.04 | ₹0.10 | −₹0.04 | −₹0.64 | ₹0.77 | ₹0.00 | ||
| −₹0.08 | ₹0.18 | ₹0.17 | −₹0.02 | −₹0.14 | ₹0.02 | ₹0.04 | ₹0.10 | −₹0.04 | −₹0.64 | ₹0.77 | ₹0.00 | ||
| ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.02 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ||
| ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.02 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ||
Regulatory disclosures — filed alongside, not part of the P&L | |||||||||||||
| — | — | — | 0.1 | — | 0.5 | — | — | — | — | — | — | ||
Adjusted (ex-exceptional items) — derived | |||||||||||||
| −0.0 | 0.1 | 0.1 | −0.0 | −0.0 | 0.0 | 0.0 | 0.0 | −0.0 | −0.3 | 0.3 | −0.0 | ||
| −0.0 | 0.1 | 0.1 | −0.0 | −0.0 | 0.0 | 0.0 | 0.0 | −0.0 | −0.2 | 0.2 | 0.0 | ||
| −₹0.08 | ₹0.18 | ₹0.17 | −₹0.02 | −₹0.14 | ₹0.04 | ₹0.04 | ₹0.10 | −₹0.04 | −₹0.64 | ₹0.77 | — | ||
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
In ₹ Crore except Per Share 3 Months Ending | Q2 FY24 30/09/2023 | Q3 FY24 31/12/2023 | Q4 FY24 31/03/2024 | Q1 FY25 30/06/2024 | Q2 FY25 30/09/2024 | Q3 FY25 31/12/2024 | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 0.0 | 0.5 | 0.2 | 0.0 | 0.3 | 0.0 | -0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | |
| Other Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | |
| Total Income | 0.0 | 0.5 | 0.2 | 0.0 | 0.3 | 0.0 | -0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | |
| Expenses | |||||||||||||
| + Employee Benefit Expense | 0.0 | 0.2 | 0.4 | 0.0 | 0.3 | 0.0 | -0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | |
| + Finance Costs | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Other Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Expenses | 0.0 | 0.2 | 0.4 | 0.1 | 0.3 | 0.0 | -0.0 | 0.1 | 0.0 | 0.1 | 0.1 | 0.0 | |
| EBITDA | 0.0 | 0.3 | -0.3 | -0.0 | 0.0 | 0.0 | 0.0 | -0.0 | -0.0 | 0.1 | -0.0 | -0.0 | |
| EBIT | 0.0 | 0.3 | -0.3 | -0.0 | 0.0 | 0.0 | 0.0 | -0.0 | -0.0 | 0.1 | -0.0 | -0.0 | |
| Profit | |||||||||||||
| PBT before Exceptional Items | -0.0 | 0.3 | -0.3 | -0.0 | 0.0 | 0.0 | 0.0 | -0.0 | -0.0 | 0.1 | 0.1 | -0.0 | |
| Pretax Income | -0.0 | 0.3 | -0.3 | -0.0 | 0.0 | 0.0 | 0.0 | -0.0 | -0.0 | 0.1 | 0.1 | -0.0 | |
| + Current Tax | -0.0 | 0.1 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Deferred Tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.0 | 0.0 | 0.0 | |
| Tax Expense | -0.0 | 0.1 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Net Movement in Regulatory Deferral Balances | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Net Income | 0.0 | 0.2 | -0.2 | -0.0 | 0.0 | 0.0 | 0.0 | -0.0 | -0.0 | 0.1 | 0.1 | -0.0 | |
| + Net Income — Continuing Ops | 0.0 | 0.2 | -0.2 | -0.0 | 0.0 | 0.0 | 0.0 | -0.0 | -0.0 | 0.1 | 0.1 | -0.0 | |
| + Other Comprehensive Income | 3.6 | -3.2 | 28.2 | 20.9 | 10.2 | -19.2 | -68.4 | 2.9 | -10.6 | 31.6 | -61.1 | 17.3 | |
| Total Comprehensive Income | 3.6 | -2.9 | 28.0 | 20.9 | 10.2 | -19.1 | -68.4 | 2.8 | -10.6 | 31.7 | -61.0 | 17.3 | |
| Per Share | |||||||||||||
| Basic EPS | 0.00 | 0.77 | -0.64 | -0.04 | 0.10 | 0.04 | 0.04 | -0.14 | -0.02 | 0.17 | 0.18 | -0.08 | |
| Diluted EPS | 0.00 | 0.77 | -0.64 | -0.04 | 0.10 | 0.04 | 0.04 | -0.14 | -0.02 | 0.17 | 0.18 | -0.08 | |
| Other Comprehensive Income — detail | |||||||||||||
| + Other Comprehensive Income | — | — | — | — | — | — | -68.4 | 2.9 | -10.6 | 31.6 | -61.1 | 17.3 | |
| + Items NOT to be Reclassified to P&L | 3.6 | -3.2 | 28.2 | 20.9 | 10.2 | -19.2 | -68.4 | 2.9 | -10.6 | 31.6 | -61.1 | 17.3 | |
| Per Share — as-filed variants | |||||||||||||
| Basic EPS — Continuing Operations | 0.00 | 0.77 | -0.64 | -0.04 | 0.10 | 0.04 | 0.02 | -0.14 | -0.02 | 0.17 | 0.18 | -0.08 | |
| Diluted EPS — Continuing Operations | 0.00 | 0.77 | -0.64 | -0.04 | 0.10 | 0.04 | 0.02 | -0.14 | -0.02 | 0.17 | 0.18 | -0.08 | |
| Basic EPS — Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Diluted EPS — Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | |||||||||||||
| Related-party Transactions — During the Period | — | — | — | — | — | — | 0.5 | — | 0.1 | — | — | — | |
| Adjusted (ex-Exceptional Items) — derived | |||||||||||||
| Pretax Income (Adjusted, as filed) | -0.0 | 0.3 | -0.3 | -0.0 | 0.0 | 0.0 | 0.0 | -0.0 | -0.0 | 0.1 | 0.1 | -0.0 | |
| Net Income Adj (tax-effected) | 0.0 | 0.2 | -0.2 | -0.0 | 0.0 | 0.0 | 0.0 | -0.0 | -0.0 | 0.1 | 0.1 | -0.0 | |
| EPS Adj | — | 0.77 | -0.64 | -0.04 | 0.10 | 0.04 | 0.04 | -0.14 | -0.02 | 0.17 | 0.18 | -0.08 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||||||||||
| Face Value | — | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |
| Paid Up Equity Capital | — | 3.1 | 3.1 | 3.1 | 3.1 | 3.1 | 3.1 | 3.1 | 3.1 | 3.1 | 3.1 | 3.1 | |
Mask Investments (NSE: MASKINVEST) will announce its Q2 FY27 results (July–September 2026) on Saturday, 31 October 2026, according to the board-meeting notice it filed on 28 October 2026. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net loss was ₹2.5 lakh, narrower than the loss of ₹4.4 lakh in Q1 FY26 and against a profit of ₹5.6 lakh in Q4 FY26. Revenue from operations was ₹2.2 lakh, down 14.2% year on year and up 7.7% from the previous quarter.
On 31 October 2026, the date of the board meeting called to approve them (notice filed with the exchanges on 28 October 2026). Last year it reported Q2 FY26 on 13 November 2025.
With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net loss was ₹0.5 lakh and revenue from operations ₹2.6 lakh. The latest quarter, Q1 FY27, had a net loss of ₹2.5 lakh and revenue of ₹2.2 lakh.
Consolidated net loss was ₹2.5 lakh, narrower than the loss of ₹4.4 lakh in Q1 FY26 and against a profit of ₹5.6 lakh in Q4 FY26. Revenue from operations was ₹2.2 lakh, down 14.2% year on year and up 7.7% from the previous quarter.
Net profit by quarter: a loss of ₹0.5 lakh in Q2 FY26, a profit of ₹5.1 lakh in Q3 FY26, a profit of ₹5.6 lakh in Q4 FY26 and a loss of ₹2.5 lakh in Q1 FY27. That is a combined profit of ₹7.8 lakh over the four quarters. Revenue from operations: ₹2.6 lakh, ₹13 lakh, ₹2.1 lakh and ₹2.2 lakh.
Consolidated net profit was ₹5.8 lakh in FY26 (April 2025–March 2026), up 68.9% from ₹3.4 lakh in FY25. It was ₹2.1 lakh in FY24 and ₹5.9 lakh in FY23: down 1.5% over three years, an average fall of 0.5% a year.
Revenue from operations was ₹10 lakh in FY26 (April 2025–March 2026), down 75.7% from ₹41 lakh in FY25. It was ₹74 lakh in FY24 and ₹31 lakh in FY23: down 67.6% over three years, an average fall of 31.3% a year.
From Mask Investments' own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.
Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.